Skip to content

Clinical trials

Observational Macular Degeneration trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Macular Degeneration Phase: Observational Country / region: Germany Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20061
20091
20111
20121
20132
20142
20152
20182
20194
20201
20221
20231
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Active, not recruiting2
Recruiting2
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer6
University Hospital, Bonn3
Novartis Pharmaceuticals2
Association for Innovation and Biomedical Research on Light and Image1
Augenheilkunde Lindenthal1
Frank G. Holz1
Genentech, Inc.1
Gyroscope Therapeutics Limited1
Klinikum Chemnitz gGmbH1
Maximilian Pfau1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Macular Degeneration22
Geographic Atrophy4
Atrophy2
Retinal Vein Occlusion2
Anetoderma1
Choroidal Neovascularization1
Epiretinal Membrane1
Eye Diseases1
Macular Edema1
Retinal Degeneration1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.